Skip to main content

Table 2 Crude prevalence of microvascular or macrovascular diseases and related procedures at baseline, overall and according to region

From: Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program)

 

Total (N = 15,992)

Africa (n = 812)

Americas (n = 2002)

South-East Asia (n = 3360)

Europe (n = 3479)

Eastern Mediterranean (n = 2182)

Western Pacific (n = 4157)

Any microvascular disease, n (%)

3005 (18.8)

118 (14.5)

302 (15.1)

556 (16.5)

812 (23.5)

399 (18.3)

818 (19.7)

 CKD

794 (5.0)

20 (2.5)

90 (4.5)

23 (0.7)

257 (7.4)

31 (1.4)

373 (9.0)

 Albuminuria

605 (4.3)

21 (2.6)

40 (2.0)

188 (5.6)

195 (5.6)

91 (4.2)

70 (3.1)

 Retinopathy

624 (3.9)

22 (2.7)

68 (3.4)

30 (0.9)

198 (5.7)

69 (3.2)

237 (5.7)

 Retinal laser photocoagulation

98 (0.6)

4 (0.5)

17 (0.8)

1 (0.0)

14 (0.4)

9 (0.4)

53 (1.3)

 Autonomic neuropathy

155 (1.0)

1 (0.1)

9 (0.4)

40 (1.2)

28 (0.8)

25 (1.1)

52 (1.3)

 Peripheral neuropathy

1237 (7.7)

47 (5.8)

114 (5.7)

324 (9.6)

324 (9.4)

181 (8.3)

247 (5.9)

 Erectile dysfunction

426 (2.7)

38 (4.7)

65 (3.2)

28 (0.8)

115 (3.3)

102 (4.7)

78 (1.9)

Any macrovascular disease, n (%)

2027 (12.7)

74 (9.1)

232 (11.6)

135 (4.0)

915 (26.7)

218 (10.0)

453 (10.9)

 Heart failure

527 (3.3)

7 (0.9)

54 (2.7)

18 (0.5)

368 (10.7)

23 (1.1)

57 (1.4)

 CAD

1310 (8.2)

59 (7.3)

151 (7.5)

91 (2.7)

622 (18.1)

172 (7.9)

215 (5.2)

  Angina

473 (3.0)

19 (2.3)

53 (2.6)

10 (0.3)

262 (7.6)

40 (1.8)

89 (2.1)

  Myocardial infarction

445 (2.8)

39 (4.8)

80 (4.0)

18 (0.5)

228 (6.6)

31 (1.4)

49 (1.2)

  PCI

424 (2.7)

10 (1.2)

62 (3.1)

19 (0.6)

184 (5.4)

70 (3.2)

79 (1.9)

  CABG

140 (0.9)

10 (1.2)

17 (0.8)

13 (0.4)

71 (2.1)

15 (0.7)

14 (0.3)

Stroke

352 (2.2)

4 (0.5)

35 (1.7)

20 (0.6)

114 (3.3)

29 (1.3)

150 (3.6)

Transient ischemic attack

107 (0.7)

3 (0.4)

14 (0.7)

1 (0.0)

36 (1.0)

17 (0.8)

36 (0.9)

Carotid artery stent

16 (0.1)

0 (0.0)

1 (0.0)

0 (0.0)

7 (0.2)

4 (0.2)

4 (0.1)

Carotid endarterectomy

16 (0.1)

0 (0.0)

0 (0.0)

0 (0.0)

12 (0.3)

1 (0.0)

3 (0.1)

PAD

197 (1.2)

4 (0.5)

15 (0.7)

2 (0.1)

108 (3.1)

10 (0.5)

58 (1.4)

  Diabetic foot

87 (0.5)

4 (0.5)

20 (1.0)

15 (0.4)

32 (0.9)

7 (0.3)

9 (0.2)

  Amputation

32 (0.2)

6 (0.7)

12 (0.6)

1 (0.0)

9 (0.3)

3 (0.1)

1 (0.0)

Defibrillator use

8 (0.1)

0 (0.0)

0 (0.0)

0 (0.0)

7 (0.2)

0 (0.0)

1 (0.0)

  1. Percentages calculated for all patients with data available; unreported data are excluded
  2. CABG coronary artery bypass grafting, CAD coronary artery disease, CKD chronic kidney disease, PAD peripheral artery disease, PCI percutaneous coronary intervention